Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xufeng Wu

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Cancer Research|December 2, 2010
Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasisHuijun Chen, Xufeng Wu, Zhixing K Pan, et al.
Chemical Communications (Cambridge, England)|April 4, 2006
Controlled one-step fabrication of highly oriented ZnO nanoneedle/nanorods arrays at near room temperatureXufeng Wu, Hua Bai, Chun Li, et al.
Gynecologic Oncology|July 9, 2008
Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized studyHuijun Chen, Chuan Liang, Lei Zhang, et al.
Journal of Cell Science|August 10, 2006
Recruitment dynamics of GAK and auxilin to clathrin-coated pits during endocytosisDong-Won Lee, Xufeng Wu, Evan Eisenberg, et al.
Current Medicinal Chemistry|November 4, 2022
Exploring Cantharidin and its Analogues as Anticancer Agents: A ReviewShaoting Li, Xufeng Wu, Gang Fan, et al.
The Journal of Physical Chemistry. B|July 21, 2006
Copper hydroxide nanoneedle and nanotube arrays fabricated by anodization of copperXufeng Wu, Hua Bai, Jiaxin Zhang, et al.
Frontiers in Oncology|June 24, 2025
CIN coexisting with AIS is a risk factor for residual disease after conization for cervical adenocarcinoma <i>in situ</i>Rong Zeng, Yulin Guo, Miao Zou, et al.
Frontiers in Oncology|August 4, 2025
Correction: CIN coexisting with AIS is a risk factor for residual disease after conization for cervical adenocarcinoma <i>in situ</i>Rong Zeng, Yulin Guo, Miao Zou, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 20, 2019
Prospective observational study of the efficacy of mixed methylene blue compound injection for treatment of vulvar non-neoplastic epithelial disordersYanli Li, Jie Shi, Wenfu Tan, et al.
Journal of Cellular Physiology|December 21, 2018
Circular RNA hsa_circ_0000263 participates in cervical cancer development by regulating target gene of miR-150-5pHongning Cai, Peng Zhang, Meng Xu, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Cancer Research|December 2, 2010
Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasisHuijun Chen, Xufeng Wu, Zhixing K Pan, et al.
Chemical Communications (Cambridge, England)|April 4, 2006
Controlled one-step fabrication of highly oriented ZnO nanoneedle/nanorods arrays at near room temperatureXufeng Wu, Hua Bai, Chun Li, et al.
Gynecologic Oncology|July 9, 2008
Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized studyHuijun Chen, Chuan Liang, Lei Zhang, et al.
Journal of Cell Science|August 10, 2006
Recruitment dynamics of GAK and auxilin to clathrin-coated pits during endocytosisDong-Won Lee, Xufeng Wu, Evan Eisenberg, et al.
Current Medicinal Chemistry|November 4, 2022
Exploring Cantharidin and its Analogues as Anticancer Agents: A ReviewShaoting Li, Xufeng Wu, Gang Fan, et al.
The Journal of Physical Chemistry. B|July 21, 2006
Copper hydroxide nanoneedle and nanotube arrays fabricated by anodization of copperXufeng Wu, Hua Bai, Jiaxin Zhang, et al.
Frontiers in Oncology|June 24, 2025
CIN coexisting with AIS is a risk factor for residual disease after conization for cervical adenocarcinoma <i>in situ</i>Rong Zeng, Yulin Guo, Miao Zou, et al.
Frontiers in Oncology|August 4, 2025
Correction: CIN coexisting with AIS is a risk factor for residual disease after conization for cervical adenocarcinoma <i>in situ</i>Rong Zeng, Yulin Guo, Miao Zou, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 20, 2019
Prospective observational study of the efficacy of mixed methylene blue compound injection for treatment of vulvar non-neoplastic epithelial disordersYanli Li, Jie Shi, Wenfu Tan, et al.
Journal of Cellular Physiology|December 21, 2018
Circular RNA hsa_circ_0000263 participates in cervical cancer development by regulating target gene of miR-150-5pHongning Cai, Peng Zhang, Meng Xu, et al.
Pageof 7